NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (U44)

Sponsor: NIH
Due Date: February 8, 2017
Award: Budget is not limited but must reflect actual needs of the project. Phase I costs should rarely exceed $2,000,000 over 2 years; Phase II costs should rarely exceed $1,500,000 per year for up to 3 years.